Leadership: Page 2
-
Pharma’s immunology field is full of blockbusters, and it’s just getting started
From the "father" of the IL-23 pathway at Janssen to a big acquisition by Merck, the ultra-competitive immunology space is still growing with the pace of innovation.
By Michael Gibney • April 27, 2023 -
Roy Vagelos is retiring and leaving a legacy of leadership lessons
The longtime pharma leader is stepping down from his role as chair of Regeneron’s board in June after decades in drug development.
By Karissa Waddick • April 25, 2023 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineCell and gene therapies
How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.
By PharmaVoice staff -
Profile
The 99 seconds that changed this CEO’s life
Peter Kirk’s marathon story of inspiration and perseverance.
By Taren Grom • April 21, 2023 -
Q&A
Cure Ventures has $350M to pour deep into biotech ‘company building’
The biotech venture capital firm Cure Ventures, led by three industry veterans, raised the inaugural fund in early April and will soon announce its seed companies.
By Michael Gibney • April 20, 2023 -
Podcast
Woman of the Week: Brii Biosciences’ Ellee de Groot
A chemical engineer by training, Brii’s chief technology officer is applying her experience to solve research problems from the clinic to commercial development.
By Taren Grom • April 19, 2023 -
Conditions for worker burnout in biotech are ripe. Here’s how to beat it
One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.
By Meagan Parrish • April 19, 2023 -
Fighting vaccine hesitancy may require a new approach from pharma
The COVID-19 pandemic highlighted an ongoing problem of vaccine hesitancy undermining public health efforts. One way pharmas can help is to change the narrative.
By Michael Gibney • April 13, 2023 -
Podcast
Woman of the Week: uMotif’s Julia Lakeland
The chief product officer’s work in transforming clinical trial technology is driven by people.
By Taren Grom • April 12, 2023 -
Profile
He helped launch the Pfizer COVID vaccine — now this startup CEO is hunting a lingering pandemic foe
All of the COVID-19 mAbs have been pulled from the market. But Dave Hering, CEO of Invivyd, hopes to change that.
By Meagan Parrish • April 11, 2023 -
Q&A
5 minutes with — Parexel’s Peyton Howell
The company’s chief operating and growth officer on her personal quirks and why every pharma leader should read "Getting Naked."
By Taren Grom • April 7, 2023 -
Despite J&J’s exit, Big Pharma is closing in on a launch of the first RSV vax this year
Although Janssen bowed out of the RSV vaccine race, several pharmas are quickly closing in on the finish line in a disease with decades of unmet need.
By Michael Gibney • April 6, 2023 -
Q&A
Amgen’s aim for a ‘moonshot’ in cardiovascular disease
A VP of global development at Amgen explains how treating general medicine diseases could one day resemble approaches in oncology.
By Taren Grom • April 5, 2023 -
Podcast
Woman of the Week: Intergalactic Therapeutics’ Dr. Theresa Heah
Welcome to the Woman of the Week podcast, a weekly discussion that illuminates the unique stories of women leaders who are catalyzing change throughout the life sciences industry. You can check out all our podcast episodes here. Dr. Theresa Heah has spent her entire career moving ophthalm...
By Taren Grom • April 5, 2023 -
Profile
Moderna exec: ‘There is nothing but global health’
How Chantal Friebertshäuser is helping lead Moderna’s plan to expand its global reach.
By Alexandra Pecci • April 4, 2023 -
Opinion
Leaders wave a magic wand at pharma’s thorniest issues
The major challenges pharma leaders would solve with a quick flick of an imaginary wand.
By PharmaVoice staff • March 31, 2023 -
Q&A
Digital biomarkers lay the groundwork for precision medicine beyond the bloodwork
Biomarkers are the hidden talent behind precision medicine, and finding them doesn't have to always come from a blood test — digital pioneers are finding another way.
By Michael Gibney • March 30, 2023 -
Seamless clinical trials were created to make studies easier — instead, they’ve become more complex
Experts weigh in on how companies can design better trials that merge two phases into one.
By Meagan Parrish • March 29, 2023 -
Podcast
Woman of the Week: Psilera’s Jackie von Salm
Psilera founder’s “third eye” approach to psychedelics ushers them into the therapeutic realm.
By Taren Grom • March 29, 2023 -
How one of the world’s sharpest inventors keeps the ideas coming. Hint: It’s not at work
Steve Quake, head of science for the Chan Zuckerberg Initiative, who’s had several “once-in-a-lifetime” ideas, provides advice on how to find inspiration.
By Alexandra Pecci • March 27, 2023 -
Opinion
What would you fix with a ‘magic wand?’ Pharma leaders chime in about clinical trials
How life science execs would transform clinical trials with a little hocus pocus.
By PharmaVoice staff • March 24, 2023 -
Everyone says they’re patient-centric, but have they really walked the walk?
Life science leaders provide practical tips on how to create a sustainable patient-focused culture.
By Karissa Waddick • March 23, 2023 -
Podcast
Woman of the Week: RIGImmune’s Susan Sobolov
RIGImmune’s president is setting her sights on an off-the-shelf viral vaccine.
By Taren Grom • March 22, 2023 -
Making the leap from the lab to the boardroom
Four academics-turned-executives share what they’ve learned about the pivot point between life sciences academia and entrepreneurship.
By Alexandra Pecci • March 21, 2023 -
A biopharma CEO’s quest for global health equity has put him in the running for a Nobel Prize
Dr. Ryan Saadi, CEO of Tevogen Bio, is making good on a lifelong goal of bringing T cell therapies to people who need them.
By Taren Grom • March 17, 2023 -
Making Moves
In the fallout from Aduhelm, Biogen’s leadership shakeup continues
The recent departure of neurodegenerative development head Samantha Budd Haeberlein is just the latest sign of a changing tide among Biogen’s post-Aduhelm leadership.
By Karissa Waddick • March 16, 2023